What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Gene
Her scientific interests lie mostly in Internal medicine, Endocrinology, Breast cancer, Cancer and Risk factor.
Internal medicine and Oncology are commonly linked in her work.
Her studies deal with areas such as Vitamin C and Endometrial cancer as well as Endocrinology.
Her Breast cancer study combines topics from a wide range of disciplines, such as Sex hormone-binding globulin, Testosterone, Dehydroepiandrosterone sulfate, Gynecology and Menstrual cycle.
Her Cancer research incorporates themes from Long term treatment, Estrogen, Pediatrics and Heparin.
Paola Muti has researched Risk factor in several fields, including Blood pressure, Liver function and Cholesterol.
Her most cited work include:
- Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. (870 citations)
- Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). (486 citations)
- Myocardial Injury after Noncardiac Surgery: A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes (441 citations)
What are the main themes of her work throughout her whole career to date?
Paola Muti mainly investigates Internal medicine, Breast cancer, Endocrinology, Cancer and Oncology.
Prospective cohort study, Case-control study, Risk factor, Body mass index and Estrogen are the subjects of her Internal medicine studies.
The concepts of her Prospective cohort study study are interwoven with issues in Nested case-control study, Cohort and Cohort study.
Her Breast cancer research is multidisciplinary, incorporating perspectives in Odds ratio, Gynecology, Epidemiology and Physiology.
As part of her studies on Endocrinology, Paola Muti often connects relevant subjects like Endometrial cancer.
The study incorporates disciplines such as Relative risk, Cancer research and microRNA in addition to Cancer.
She most often published in these fields:
- Internal medicine (51.97%)
- Breast cancer (32.24%)
- Endocrinology (25.99%)
What were the highlights of her more recent work (between 2015-2021)?
- Cancer research (15.79%)
- Internal medicine (51.97%)
- Cancer (22.04%)
In recent papers she was focusing on the following fields of study:
Paola Muti spends much of her time researching Cancer research, Internal medicine, Cancer, microRNA and Oncology.
Her Internal medicine study frequently draws connections to adjacent fields such as Canagliflozin.
The Cancer study combines topics in areas such as DNA damage, Bioinformatics, DNA repair, Cell biology and Melatonin.
Her work deals with themes such as Carcinogenesis and Lung cancer, Pathology, which intersect with microRNA.
Paola Muti interconnects Chemotherapy, Diabetes mellitus, Progesterone receptor, Case-control study and Prostate cancer in the investigation of issues within Oncology.
Her biological study spans a wide range of topics, including Androgen, Testosterone, Prospective cohort study, Estrogen and Adjuvant therapy.
Between 2015 and 2021, her most popular works were:
- Melatonin and Hippo Pathway: Is There Existing Cross-Talk? (103 citations)
- Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma (71 citations)
- The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration (61 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Her primary scientific interests are in Cancer research, Cancer, microRNA, Metformin and Pathology.
Her Cancer research research is multidisciplinary, relying on both Cell culture, Cell migration, Cell growth, Protein kinase A and Head and neck squamous-cell carcinoma.
Her Cancer study incorporates themes from Melatonin, Hormone, DNA repair and Cell biology.
Metformin is a subfield of Internal medicine that Paola Muti explores.
Her research integrates issues of Gene expression profiling, Carcinogenesis, Gene, Normal tissue and Recurrence risk in her study of Pathology.
Her work in Breast cancer covers topics such as Meta-analysis which are related to areas like Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
